1. F. Ducray, E. Criniere, A. Idbaih, K. Mokhtari, Y. Marie, S. Paris, S. Navarro, F. Laigle-Donadey, C. Dehais, J. Thillet, K. Hoang-Xuan, J. Y. Delattre, and M. Sanson. alpha-Internexin expression identifies 1p19q codeleted gliomas. Neurology, 72(2):156-61, 2009. Note: Journal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Brain Neoplasms/diagnosis/*genetics, Chromosomes, Human, Pair 1/*genetics, Chromosomes, Human, Pair 19/*genetics, DNA Mutational Analysis, Disease Progression, Gene Deletion, Genes, Genetic Predisposition to Disease/*genetics, Genetic Screening, Genotype, Glioma/diagnosis/*genetics, Humans, Intermediate Filament Proteins/*genetics, Mutation/genetics, Oligodendroglioma/diagnosis/genetics, Predictive Value of Tests, Prognosis.



2. F. Ducray, S. El Hallani, and A. Idbaih. Diagnostic and prognostic markers in gliomas. Curr Opin Oncol, 21(6):537-42, 2009. Note: Journal ArticleUnited States. [WWW]



3. F. Ducray, Y. Marie, and M. Sanson. IDH1 and IDH2 mutations in gliomas. N Engl J Med, 360(21):2248;-author, 2009. Note: CommentLetterUnited States. [WWW] Keyword(s): Brain Neoplasms/*genetics, Gene Expression Profiling, Glioma/*genetics, Humans, Isocitrate Dehydrogenase/*genetics, *Mutation, Prognosis.



4. S. El Hallani, F. Ducray, A. Idbaih, Y. Marie, B. Boisselier, C. Colin, F. Laigle-Donadey, M. Rodero, O. Chinot, J. Thillet, K. Hoang-Xuan, J. Y. Delattre, and M. Sanson. TP53 codon 72 polymorphism is associated with age at onset of glioblastoma. Neurology, 72(4):332-6, 2009. Note: Comparative StudyJournal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Adolescent, Adult, Age Factors, Age of Onset, Aged, Aged, 80 and over, Codon/blood/*genetics, Female, Follow-Up Studies, Gene Frequency/genetics, Genetic Variation/genetics, Glioblastoma/blood/epidemiology/*genetics, Humans, Male, Middle Aged, Mutation/genetics, Polymorphism, Single Nucleotide/*genetics, Tumor Suppressor Protein p53/blood/*genetics, Young Adult.



5. A. Rousseau, A. Idbaih, F. Ducray, E. Criniere, M. Fevre-Montange, A. Jouvet, and J. Y. Delattre. Specific chromosomal imbalances as detected by array CGH in ependymomas in association with tumor location, histological subtype and grade. J Neurooncol, 2009. Note: Journal article. [WWW]



6. M. Sanson, Y. Marie, S. Paris, A. Idbaih, J. Laffaire, F. Ducray, S. El Hallani, B. Boisselier, K. Mokhtari, K. Hoang-Xuan, and J. Y. Delattre. Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas. J Clin Oncol, 27(25):4150-4, 2009. Note: Journal ArticleResearch Support, Non-U.S. Gov'tUnited Statesofficial journal of the American Society of Clinical Oncology. [WWW] Keyword(s): Adolescent, Adult, Aged, Aged, 80 and over, Brain Neoplasms/enzymology/*genetics/mortality/pathology/therapy, Codon, DNA Methylation, DNA Modification Methylases/genetics, DNA Repair Enzymes/genetics, Disease-Free Survival, Female, Gene Expression Regulation, Enzymologic, Gene Expression Regulation, Neoplastic, Glioma/enzymology/*genetics/mortality/pathology/therapy, Humans, Isocitrate Dehydrogenase/*genetics, Kaplan-Meiers Estimate, Male, Middle Aged, *Mutation, Neoplasm Staging, Promoter Regions, Genetic, Proportional Hazards Models, Risk Assessment, Time Factors, Treatment Outcome, Tumor Markers, Biological/*genetics, Tumor Suppressor Proteins/genetics, Young Adult.



7. F. Ducray, A. Benouaich-Amiel, A. Idbaih, A. Rousseau, F. Laigle-Donadey, J. Y. Delattre, and M. Sanson. Complete response after one cycle of temozolomide in an elderly patient with glioblastoma and poor performance status. J Neurooncol, 88(2):185-8, 2008. Note: Case ReportsJournal ArticleNetherlands. [WWW] Keyword(s): Aged, Antineoplastic Agents, Alkylating/*therapeutic use, Brain Neoplasms/complications/*drug therapy/genetics/pathology, Chromosome Deletion, Chromosomes, Human, X/genetics, DNA Methylation, DNA Modification Methylases/genetics, DNA Repair Enzymes/genetics, Dacarbazine/*analogs & derivatives/therapeutic use, Female, Glioblastoma/complications/*drug therapy/genetics/pathology, Humans, Tomography, X-Ray Computed, Tumor Suppressor Proteins/genetics.



8. F. Ducray, A. Idbaih, A. de Reynies, I. Bieche, J. Thillet, K. Mokhtari, S. Lair, Y. Marie, S. Paris, M. Vidaud, K. Hoang-Xuan, O. Delattre, J. Y. Delattre, and M. Sanson. Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile. Mol Cancer, 7:41, 2008. Note: Journal ArticleEngland. [WWW]



9. A. Idbaih, R. Carvalho Silva, E. Criniere, Y. Marie, C. Carpentier, B. Boisselier, S. Taillibert, A. Rousseau, K. Mokhtari, F. Ducray, J. Thillet, M. Sanson, K. Hoang-Xuan, and J. Y. Delattre. Genomic changes in progression of low-grade gliomas. J Neurooncol, 90(2):133-40, 2008. Note: Journal ArticleResearch Support, Non-U.S. Gov'tNetherlands. [WWW] Keyword(s): Adult, Chromosome Deletion, Chromosomes, Disease Progression, Female, Genome/*genetics, Glioma/*genetics/*metabolism, Humans, Male, Microsatellite Repeats, Middle Aged, Nucleic Acid Hybridization/methods.



10. G. Kaloshi, S. Everhard, F. Laigle-Donadey, Y. Marie, S. Navarro, K. Mokhtari, A. Idbaih, F. Ducray, J. Thillet, K. Hoang-Xuan, J. Y. Delattre, and M. Sanson. Genetic markers predictive of chemosensitivity and outcome in gliomatosis cerebri. Neurology, 70(8):590-5, 2008. Note: Clinical TrialJournal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Adolescent, Adult, Aged, Antineoplastic Agents, Alkylating/*therapeutic use, Chromosome Mapping, *Chromosomes, Human, Pair 19, Cohort Studies, DNA Mutational Analysis, Dacarbazine/*analogs & derivatives/therapeutic use, Disease-Free Survival, Female, Genetic Markers/physiology, Humans, Male, Middle Aged, Neoplasms, Neuroepithelial/*drug therapy/*genetics, O(6)-Methylguanine-DNA Methyltransferase/*metabolism, Prognosis, Retrospective Studies, Tumor Markers, Biological.



11. S. El Hallani, Y. Marie, A. Idbaih, M. Rodero, B. Boisselier, F. Laigle-Donadey, F. Ducray, J. Y. Delattre, and M. Sanson. No association of MDM2 SNP309 with risk of glioblastoma and prognosis. J Neurooncol, 85(3):241-4, 2007. Note: Journal ArticleResearch Support, Non-U.S. Gov'tNetherlands. [WWW] Keyword(s): Adult, Aged, Aged, 80 and over, Brain Neoplasms/*genetics/mortality/pathology, Case-Control Studies, Female, Gene Expression Regulation, Neoplastic/genetics, Genetic Predisposition to Disease, Glioblastoma/*genetics/mortality/pathology, Humans, Male, Middle Aged, Polymorphism, Single Nucleotide, Prognosis, Proto-Oncogene Proteins c-mdm2/*genetics, Reference Values, Risk Factors, Survival Analysis, Tumor Markers, Biological/*genetics.



12. A. Idbaih, A. Omuro, F. Ducray, and K. Hoang-Xuan. Molecular genetic markers as predictors of response to chemotherapy in gliomas. Curr Opin Oncol, 19(6):606-11, 2007. Note: Journal ArticleReviewUnited States. [WWW] Keyword(s): Antineoplastic Agents/*therapeutic use, Brain Neoplasms/*drug therapy/*genetics/metabolism, Chromosome Deletion, Chromosomes, Human, Pair 1, Chromosomes, Human, Pair 19, *Gene Expression Regulation, Neoplastic, Glioma/*drug therapy/*genetics/metabolism, Humans, O(6)-Methylguanine-DNA Methyltransferase/genetics, Pharmacogenetics, Prognosis, Treatment Outcome, Tumor Markers, Biological/*biosynthesis/genetics.

This material is presented to ensure timely dissemination of scholarly and technical work. Copyright and all rights therein are retained by authors or by other copyright holders. All person copying this information are expected to adhere to the terms and constraints invoked by each author's copyright. In most cases, these works may not be reposted without the explicit permission of the copyright holder.

Les documents contenus dans ces répertoires sont rendus disponibles par les auteurs qui y ont contribué en vue d'assurer la diffusion à temps de travaux savants et techniques sur une base non-commerciale. Les droits de copie et autres droits sont gardés par les auteurs et par les détenteurs du copyright, en dépit du fait qu'ils présentent ici leurs travaux sous forme électronique. Les personnes copiant ces informations doivent adhérer aux termes et contraintes couverts par le copyright de chaque auteur. Ces travaux ne peuvent pas être rendus disponibles ailleurs sans la permission explicite du détenteur du copyright.

This document was translated from BibT_EX by bibtex2html